These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Chemical End Group Modified Diblock Copolymers Elucidate Anchor and Chain Mechanism of Membrane Stabilization. Houang EM; Haman KJ; Kim M; Zhang W; Lowe DA; Sham YY; Lodge TP; Hackel BJ; Bates FS; Metzger JM Mol Pharm; 2017 Jul; 14(7):2333-2339. PubMed ID: 28538101 [TBL] [Abstract][Full Text] [Related]
7. Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach. Townsend D; Yasuda S; Metzger J Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):99-109. PubMed ID: 17187461 [TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393 [TBL] [Abstract][Full Text] [Related]
9. Modifiers of heart and muscle function: where genetics meets physiology. Swaggart KA; McNally EM Exp Physiol; 2014 Apr; 99(4):621-6. PubMed ID: 24213858 [TBL] [Abstract][Full Text] [Related]
10. Duchenne muscular dystrophy: pathogenesis and promising therapies. Chang M; Cai Y; Gao Z; Chen X; Liu B; Zhang C; Yu W; Cao Q; Shen Y; Yao X; Chen X; Sun H J Neurol; 2023 Aug; 270(8):3733-3749. PubMed ID: 37258941 [TBL] [Abstract][Full Text] [Related]
11. Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs. Townsend D; Turner I; Yasuda S; Martindale J; Davis J; Shillingford M; Kornegay JN; Metzger JM J Clin Invest; 2010 Apr; 120(4):1140-50. PubMed ID: 20234088 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392 [TBL] [Abstract][Full Text] [Related]
13. Molecular homing and retention of muscle membrane stabilizing copolymers by non-invasive optical imagingĀ in vivo. Batti Angulski AB; Cohen H; Kim M; Hahn D; Van Zee N; Lodge TP; Hillmyer MA; Hackel BJ; Bates FS; Metzger JM Mol Ther Methods Clin Dev; 2023 Mar; 28():162-176. PubMed ID: 36654800 [TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of the sarcolemma-enriched fraction from dystrophic mdx-4cv skeletal muscle. Murphy S; Zweyer M; Henry M; Meleady P; Mundegar RR; Swandulla D; Ohlendieck K J Proteomics; 2019 Jan; 191():212-227. PubMed ID: 29408692 [TBL] [Abstract][Full Text] [Related]
16. Lack of MG53 in human heart precludes utility as a biomarker of myocardial injury or endogenous cardioprotective factor. Lemckert FA; Bournazos A; Eckert DM; Kenzler M; Hawkes JM; Butler TL; Ceely B; North KN; Winlaw DS; Egan JR; Cooper ST Cardiovasc Res; 2016 May; 110(2):178-87. PubMed ID: 26790476 [TBL] [Abstract][Full Text] [Related]
17. Ultra-structural time-course study in the C. elegans model for Duchenne muscular dystrophy highlights a crucial role for sarcomere-anchoring structures and sarcolemma integrity in the earliest steps of the muscle degeneration process. Brouilly N; Lecroisey C; Martin E; Pierson L; Mariol MC; Qadota H; Labouesse M; Streichenberger N; Mounier N; Gieseler K Hum Mol Genet; 2015 Nov; 24(22):6428-45. PubMed ID: 26358775 [TBL] [Abstract][Full Text] [Related]